Indication

Rheumatoid arthritis

Rheumatoid arthritis is a chronic, systemic autoimmune inflammatory disorder that primarily targets the synovial membrane of diarthrodial joints. Read more about Rheumatoid arthritis

1,535 drugs 456 manufacturers

Advertisement

Drugs that treat it

Common Rheumatoid arthritis therapies.

Showing 415–423 of 1,535 drugs

DEXAMETHASONE

GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+61
STI PHARMA, LLC

ASPIRIN

NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES·ACUTE MYOCARDIAL INFARCTION·+16
UNIFIRST FIRST

I-PRIN (ibuprofen)

NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES·DYSMENORRHEA·+6
UNIFIRST FIRST
Filter & compare in the drug finder →Opens the drug finder with Rheumatoid arthritis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Rheumatoid arthritis.

Rheumatoid arthritis is a chronic, systemic autoimmune inflammatory disorder that primarily targets the synovial membrane of diarthrodial joints.

Although it can manifest at any age and exhibits a predilection for adult females, its clinical hallmark is persistent, symmetric polyarthritis affecting small peripheral joints—such as the metacarpophalangeal, proximal interphalangeal, and metatarsophalangeal joints—frequently presenting with morning stiffness, swelling, and tenderness.

Pathophysiologically, immune-mediated synovitis stimulates synovial hyperplasia, pannus formation, and enzymatic release, ultimately leading to progressive articular cartilage destruction and marginal bone erosions.

Left uncontrolled, the condition produces progressive joint deformities, chronic functional disability, and diverse extra-articular manifestations involving the pulmonary, cardiovascular, and ocular systems.

Personalize your experience

Follow Rheumatoid arthritis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it